Misplaced Pages

Methylarginine: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 17:00, 3 August 2011 editYikrazuul (talk | contribs)Rollbackers1,991 edits svg← Previous edit Revision as of 17:00, 11 November 2011 edit undoLouisajb (talk | contribs)Extended confirmed users4,402 edits added chembl idNext edit →
Line 9: Line 9:
| CASNo=17035-90-4 | CASNo=17035-90-4
| PubChem=132862 | PubChem=132862
| ChEMBL = 256147
| SMILES=CN=C(N)NCCC(C(=O)O)N | SMILES=CN=C(N)NCCC(C(=O)O)N
}} }}

Revision as of 17:00, 11 November 2011

Methylarginine
Names
IUPAC name (2S)-2-Amino-5-pentanoic acid
Other names Targinina; Targininum; Targinine; omega-N-Methylarginine; L-Monomethylarginine; N-Methyl-L-arginine; N-Monomethyl-L-arginine; NG-monomethyl-L-arginine
Identifiers
CAS Number
3D model (JSmol)
Abbreviations L-NMMA
ChEMBL
PubChem CID
CompTox Dashboard (EPA)
SMILES
  • CN=C(N)NCCC(C(=O)O)N
Properties
Chemical formula C7H16N4O2
Molar mass 188.23 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). checkverify (what is  ?) Infobox references
Chemical compound

N-Methylarginine is an inhibitor of nitric oxide synthase. Chemically, it is a methyl derivative of the amino acid arginine. It is used as a biochemical tool in the study of physiological role of nitric oxide.

See also

References

  1. Toutouzas, K.; Riga, M.; Stefanadi, E.; Stefanadis, C. (2008). "Asymmetric dimethylarginine (ADMA) and other endogenous nitric oxide synthase (NOS) inhibitors as an important cause of vascular insulin resistance". Hormone and Metabolic Research. 40 (9): 655–659. doi:10.1055/s-0028-1083814. PMID 18792879.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Categories: